БУХОРО ВИЛОЯТИ ПОПУЛЯЦИЯСИ УРТАСИДА ГЕНДЕР ТАФОВУТИ БЎЙИЧА АЛКОГОЛИ ЖИГАР КАСАЛЛИКЛАРИНИНГ ТАРКАЛИШ ДАРАЖАСИНИ ТАХЛИЛ КИЛИШ
Abstract
Мавзунинг долзарблиги: Алкоголли жигар касалликлари жуда кенг
тарқалган касалликлар турига кириб ўз навбатида юқори клиник ва социал
ахамиятга эга булиб, купчилик холатларда беморни яшаш ва сифат тарзини
бузилишига ва ногиронликка олиб келувчи глобал муаммолардан бири
хисобланади. Бугунги кунда алкоголли жигар касалликларининг ривожланиш
механизмида биринчи ўринда ўткир ва сурункали вирусли гепатитлардан
кейинги ўринда алкоголи жигар касалликлари(АЖК) эгаллайди. АЖК нинг
бир неча нозологик турлари қуйидагича фаркланади Ёғли гепатоз – стеатоз ,
алкоголли гепатит , алкоголли жигар цирроози,
References
Фойдаланлган адабиётлар рўйхати:
1. Tilg, H. Management strategies in alcoholic liver disease / H. Tilg, C.P. Day // Nat.
Clin. Pract. Gastroenterol. Hepatol. – 2007. – Vol.4, №1. – P. 24-34.
2. Chronic liver disease – an increasing problem: a study of hospital admission and
mortality rates in England, 1975-2005, with particular reference to alcoholic liver
disease / S.J. Thomson, S. Westlake, T.M. Rahman et al. // Alcohol Alcohol. – 2008.
– Vol. 43, № 4. – P.416-422.
3. Sivolap, Yu.P. Alcoholism and the consequences of alcohol abuse / Yu.P. Sivolap,
V.A. Savchenkov // The attending physician. – 2008. – No. 4. – pp. 66-67.
4. Ramsted, M. Population drinking and liver cirrhosis mortality: is there link in
Eastern Europe? / M. Ramsted // Addiction. – 2007. – Vol.102, № 8. – P.1212-
1223.
5. Alcohol in the European region – consumption, harm and politics // Narcology. -
2006. – No. 3. – pp.24-30.
6. Epidemiology of alcohol- related liver and pancreatic disease in the United States /
A.L. Yang, S. Vadhavkar, G. Singh, M.B. Omary // Arch. Intern. Med. – 2008. –
Vol.168, № 6. – P. 649-656.
7. Mann, R.E. The epidemiology of alcoholic liver disease / R.E. Mann, R.G. Smart,
R. Govoni // Alcohol Res. Health. – 2003. – Vol.27, № 3. – P. 209-219.
8. Vaiphei, K. Chronic alcohol intake: indicator towards alcoholic liver disease / K.
Vaiphei, K. Gupta, V. Lal // Indian J. Gastroenterol. – 2007. – Vol. 26, № 4. –
P.180-184.
9. De Ritis ratio as diagnostic marker of alcoholic liver disease / S. Majhi, N. Baral,
M. Lamsal, K.D. Mehta // Nepal Med. Coll. J. – 2006 – Vol.8, № 1. – P.40-42.
10. Horie, Y. Severe alcoholic hepatitis in Japan: prognosis and therapy / Y. Horie, H.
Ishii, T. Hibi // Alcohol. Clin. Exp. Res. – 2005 – Vol.29, Suppl. 12. – S.251-258.
11. Nemtsov, A.V. Comparative analysis of the alcohol situation in Belarus and Russia
/A.V. Nemtsov, K.V. Davydov, Yu.E. Razvodovsky // Narcology. – 2009. – No. 1.
– pp.52-60.
12. Etiological factors of cirrhosis of the liver with fatal outcomes / A.I. Pavlov, S.V.
Plyusnin, A.I. Khazanov et al. // Russian Journal of gastroenterol., hepatol.,
coloproctol. – 2005. – Vol. 15, No. 2. – Pp.68-72.
13. Babak, O.Ya. Alcoholic liver disease: scientific achievements and clinical prospects
/ O.Ya. Babak // Suchasna gastroenterology. – 2006. – № 6(32). – Pp. 4-9.
14. Ramsted, M. Alcohol consumption and liver cirrhosis mortality with and without
mention of alcohol – the case of Canada / M. Ramsted // Addiction. – 2003. – Vol.
98, № 9. – P.1267-1276.
15. Incidence rates and causes of cirrhosis in Norwegian population /J.M. Haukeland,
I. Lorgen, L.T. Schreiner et al. // Scand. J. Gastroenterol. – 2007. – Vol.42, № 12.
– P.1501-1508.
16. Khazanov, A.I. Evolution of etiological factors of liver cirrhosis based on the results
of 58-year observations of patients in a large multidisciplinary hospital / A.I.
Khazanov // Russian Journal of gastroenterology, hepatol, coloproctol. – 2004. –
Vol.14, No. 3. – pp.66-72.
17. Klatskin, G. Alcohol and its relation to liver damage / G. Klatskin //
Gastroenterology. – 1961. – Vol. 41. – P. 443-449.
18. Penguignot, G. Die Rolle des Alkohos bei der Atiologie von Leber Zirrhosen in
Frankreich / G. Penguignot // Munch. Med. Wschr. – 1961. – Bd. 103. – S. 1464-
1471.
19. Naveau, S. Current trend: alcoholic liver disease / S. Naveau // Gastroenterol. Clin.
Biol. – 2006. – Vol.30, № 4. –P.550-553.
20. Savolainen, V.T. Delayed increases in liver cirrhosis following an increament and
redistribution of alcohol consumption in covering 8533 asses in 1986-1988 / V.T.
Savolainen, A. Pentila, P. J. Karhuncn // Alcohol Clin. Exp. Res. – 1992. -Vol.16,
№ 4. – P.661-664.
21. Khazanov, A.I. Possibilities of progression of alcoholic and non–alcoholic
steatohepatitis into cirrhosis of the liver / A.I. Khazanov // Russian Journal of
gastroenterology, hepatologist, coloproctologist. – 2005. – No. 2. - pp. 26-32.
22. Severe alcohol-induced liver disease and the alcohol dependence syndrome /S.
Smith, J. White, C. Nelson et al. // Alcohol Alcohol. – 2006. – Vol. 41, № 3. – P.
274-277.
23. Abdurakhmanov, D.T. Alcoholic hepatitis: clinical characteristics, course,
prognosis / D.T. Abdurakhmanov // Pharmateka. - 2008. – No. 2. – pp. 25-32.
24. Stiefelhagen, P. Alcohol drinking is the major cause of chronic liver diseases, but it
does not just depend on the dose / P. Stiefelhagen // MMW Fortschr. Med. – 2008.
– Vol.150, № 18. – с.18.
25. S.P. Chernov, V.B. Lifshits, V.G. Subbotina et al. Epidemiology of alcoholic liver
disease . Saratov Journal of Medical Science, 2009, volume 5, No. 4, pp. 564-568.
26. Nurbaev F.E. Raupov A.O. Sharipova N.K. Dzhumaev H. Liver lesions in GOVID-
19 : etiology, clinic, prognosis, treatment and prevention. Bukhara scientific-
abstract , spiritual and educational journal 11(49)2022 p. 475- 481
27. Nurbaev F.E. Mavlyanov S.I. Pharmacoeconomical analysis of the effectiveness of
therapy for chronic hepatitis "C" . Tibbet va sport 2021/No.2 pp.103-108
28. Nurbayev F.E. Pharmacoeconomic analysis of efficiencytherapy chronic hepatits
“C” World medicine journal p.152-162 NO 1 (3) 2022y.
29. Nurbaev F.E. Dzhumaev B.Z. “Optimization of modern pharmacotherapy of
chronic diffuse liver diseases with predominance of cholestasis syndrome” New
Day in medicine 2018. No. 1 27-30 p.
30. Nurbaev F.E. Khamraeva Yu.S., "Pharmacoenomic analysis of the costs of
treatment of chronic hepatitis "In" inpatient conditions (Retrospective study)" A
New Day in Medicine.2017.No. 4. 38-44 p.
31. Nurbaev.F.E. B.Z.Dzhumaev., "Ways to increase the pharmacoeconomical
effectiveness of intrahepatic syndrome therapy." A New Day in Medicine.2017.No.
4.38-44 p.
